1. Home
  2. BY vs CDNA Comparison

BY vs CDNA Comparison

Compare BY & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Byline Bancorp Inc.

BY

Byline Bancorp Inc.

HOLD

Current Price

$38.11

Market Cap

1.8B

Sector

Finance

ML Signal

HOLD

Logo CareDx Inc.

CDNA

CareDx Inc.

N/A

Current Price

$50.80

Market Cap

1.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BY
CDNA
Founded
1914
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.5B
IPO Year
2017
2007

Fundamental Metrics

Financial Performance
Metric
BY
CDNA
Price
$38.11
$50.80
Analyst Decision
Buy
Buy
Analyst Count
2
6
Target Price
$36.00
$28.00
AVG Volume (30 Days)
209.4K
1.1M
Earning Date
04-23-2026
04-28-2026
Dividend Yield
1.48%
N/A
EPS Growth
5.09
N/A
EPS
1.73
2.13
Revenue
N/A
$48,324,000.00
Revenue This Year
$16.89
$16.01
Revenue Next Year
$3.15
$11.31
P/E Ratio
$22.18
$22.30
Revenue Growth
N/A
18.93
52 Week Low
$25.57
$12.37
52 Week High
$40.03
$49.76

Technical Indicators

Market Signals
Indicator
BY
CDNA
Relative Strength Index (RSI) 47.96 68.55
Support Level $38.31 $44.80
Resistance Level $38.86 $49.76
Average True Range (ATR) 0.57 1.78
MACD -0.20 -0.39
Stochastic Oscillator 29.70 89.88

Price Performance

Historical Comparison
BY
CDNA

About BY Byline Bancorp Inc.

Byline Bancorp Inc is the holding company for Byline Bank, a full-service commercial bank serving small-and-medium sized businesses, financial sponsors, and consumers. The company offers a broad range of banking products and services to small and medium sized businesses, commercial real estate and online account opening to consumer and business. Also provide trust and wealth management services to its customers. In addition to traditional commercial banking business, company provide small ticket equipment leasing solutions through a wholly-owned subsidiary of Byline Bank.

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

Share on Social Networks: